Fig1: Western blot analysis of TAL1 expression in non-transfected (A) and human TAL1 transfected (B) 293T whole cell lysates and CCRF-CEM (C), Jurkat (D) and K-562 (E) nuclear extracts.
bHLHa17 antibody
Class A basic helix-loop-helix protein 17 antibody
OTTHUMP00000009563 antibody
OTTHUMP00000009564 antibody
SCL antibody
STEM CELL LEUKEMIA HEMATOPOIETIC TRANSCRIPTION FACTOR antibody
Stem cell protein antibody
T cell acute lymphocytic leukemia 1 antibody
T cell acute lymphocytic leukemia 1 protein antibody
T cell acute lymphocytic leukemia 1 protein antibody
T cell leukemia/lymphoma 5 protein antibody
T-cell acute lymphocytic leukemia protein 1 antibody
T-cell leukemia/lymphoma protein 5 antibody
Tal 1 antibody
Tal 1 product antibody
TAL 1 protein antibody
TAL-1 antibody
tal1 antibody
TAL1_HUMAN antibody
TCL 5 antibody
TCL5 antibody
Product description
Activation of TAL1 characterizes up to 60% of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. This transcription factor binds as a heterodimer with E2A and HEB/HTF4 to a nucleotide sequence motif termed the E-box. In addition, leukemogenesis is accelerated dramatically by transgenic coexpression of TAL1 and the catalytic subunit of casein kinase IIα, a serine/ threonine protein kinase known to modulate the activity of other βHLH transcription factors.
Immunogen
peptide
Key Feature
Clonality
Monoclonal
Isotype
IgG1
Host Species
Mouse
Tested Applications
WBIPIF
WB:1:100-1:1,000 IP:1-2 μg per 100-500 μg of total protein(1 ml of cell lysate) IF:1:50-1:500
Species Reactivity
HumanMouseRat
Concentration
2mg/ml
Target Information
Alternative Names
bHLHa17 antibody
Class A basic helix-loop-helix protein 17 antibody
OTTHUMP00000009563 antibody
OTTHUMP00000009564 antibody
SCL antibody
STEM CELL LEUKEMIA HEMATOPOIETIC TRANSCRIPTION FACTOR antibody
Stem cell protein antibody
T cell acute lymphocytic leukemia 1 antibody
T cell acute lymphocytic leukemia 1 protein antibody
T cell acute lymphocytic leukemia 1 protein antibody
T cell leukemia/lymphoma 5 protein antibody
T-cell acute lymphocytic leukemia protein 1 antibody
T-cell leukemia/lymphoma protein 5 antibody
Tal 1 antibody
Tal 1 product antibody
TAL 1 protein antibody
TAL-1 antibody
tal1 antibody
TAL1_HUMAN antibody
TCL 5 antibody
TCL5 antibody
Fig1: Western blot analysis of TAL1 expression in non-transfected (A) and human TAL1 transfected (B) 293T whole cell lysates and CCRF-CEM (C), Jurkat (D) and K-562 (E) nuclear extracts.
Positive Control
293T, CCRF-CEM, Jurkat, K-562
Application Notes
WB:1:100-1:1,000 IP:1-2 μg per 100-500 μg of total protein(1 ml of cell lysate) IF:1:50-1:500